23 Jul TISSUE-SPECIFIC GENOME ENGINEERING USING CRISPR-CAS9
Abstract
The present application provides compounds, compositions, uses thereof for the treatment of diseases, conditions and/or disorders, and uses thereof as asialoglycoprotein receptor (ASGPR) targeting agents.
Year: 2017
Country: US
Doc No: 2017137801